Developer docs
API playgroundTry for free, no card

Search company profiles

Cooler Heads

Full company profile

uuid00007bp

Namestring
Cooler Heads
Legal namestring
Cooler Heads Care, Inc.
Websiteurl
coolerheads.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Cooler Heads Care, Inc. is a privately held medical device company headquartered in San Diego, California, founded in 2018 by breast cancer survivor and tech entrepreneur Kate Dilligan. The company develops and commercializes the Amma Scalp Cooling System, an FDA-cleared (K211526) portable mechanical device intended to reduce the likelihood of chemotherapy-induced alopecia in adults 21 and older being treated for solid tumors. The technology circulates chilled fluid through a fitted cooling wrap to lower scalp temperature, constricting blood vessels and limiting chemotherapy delivery to hair follicles; the system comprises a Cooling Wrap, Neoprene Strap, Compression Cap, and Portable Cooling Unit, and is differentiated from traditional cold capping by its continuous cooling (no mid-session cap swaps) and portability within infusion centers.

Cooler Heads sells Amma through a direct enterprise field-sales motion targeting U.S. hospitals, cancer centers, and infusion facilities, providing staff training, demo requests, and onboarding support. As of early 2025 the company reported active accounts in 22 states, with named adopters including Sharp HealthCare, St. Clair Health, OSF Healthcare, UPMC Magee, Detroit Medical Center, Beebe Healthcare, Southeast Georgia Healthcare System, and The Christ Hospital. Healthcare providers bill scalp cooling services using CPT codes 97007, 97008, and 97009; the American Medical Association elevated these codes to Category I effective January 2026, with CMS-proposed payment rates and New York Medicaid coverage effective April 1, 2026 — both meaningful reimbursement tailwinds.

The company has raised approximately $12.5M in disclosed venture funding across a 2021 seed ($1.5M), a 2023 round ($8M), and a July 2025 oversubscribed $11M Series A led by Mutual Capital Partners with participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor. Proceeds are earmarked for manufacturing scale-up, commercial team expansion (including dedicated West and East regional AVP coverage and a market-access function), and next-generation product development. The company employs 11–50 people and operates without a parent company or public listing.

Short descriptiontext

Cooler Heads Care develops the Amma portable scalp cooling system, an FDA-cleared medical device that helps chemotherapy patients with solid tumors prevent hair loss. The company sells directly to U.S. infusion centers and cancer treatment facilities from its San Diego headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
scalp cooling system, chemotherapy hair loss prevention, portable medical device, oncology infusion equipment, FDA-cleared medical device
Industry1 code
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Scalp Cooling Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Device/System Sales to Healthcare Facilities
TypeHardware Sales
Description

Cooler Heads provides Amma scalp cooling systems to infusion centers and cancer treatment facilities. Healthcare providers bill using Category I CPT codes (97007, 97008, 97009) for mechanical scalp cooling services. Out-of-pocket expenses vary based on insurance coverage eligibility, plan-specific details, and facility charges.

coolerheads.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Others
Pricing details1 tier
1Insurance coverage varies by plan
ModelOtherBilling cadencePay-as-you-go
Notes

Coverage for scalp cooling varies by payer. Patients should speak with their healthcare provider's billing department to understand their specific financial responsibility. Self-pay options may be available for uninsured or underinsured patients.

coolerheads.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Amma
Description

FDA-cleared portable scalp cooling system designed to help chemotherapy patients prevent hair loss. Consists of a Cooling Wrap, Neoprene Strap, Compression Cap, and Portable Cooling Unit.

coolerheads.com
Core offering1 text field

Cooler Heads sells the Amma Scalp Cooling System, an FDA-cleared portable medical device used in oncology infusion centers to reduce chemotherapy-induced hair loss in adult patients with solid tumors. The system circulates chilled fluid through a fitted wrap before, during, and after chemotherapy treatment to constrict blood vessels and limit chemotherapy delivery to hair follicles. Healthcare facilities acquire the device and bill patients and insurers using Category I CPT codes (97007, 97008, 97009) for mechanical scalp cooling services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cooler Heads offers the Amma Scalp Cooling System, an FDA-cleared portable medical device designed to help chemotherapy patients prevent hair loss. The system is a unified product consisting of five integrated components: a Portable Cooling Unit that circulates chilled solution, a Cooling Wrap that delivers the solution to the scalp, a Neoprene Strap for compression, and a Compression Cap to hold everything in place. Once fitted, the wrap stays on for the entire session. The system is intended for adults 21 and older with solid tumors and is currently available at participating infusion centers across the United States.

Product and service1 record
1Amma Scalp Cooling System
CategoryScalp Cooling Medical Devices
Description

FDA-cleared portable scalp cooling system designed to help adult (21+) chemotherapy patients with solid tumors prevent hair loss by cooling the scalp before, during, and after treatment. The system is sold to oncology infusion centers and cancer treatment facilities, which then bill patients and insurers using Category I CPT codes (97007, 97008, 97009). The system integrates a Portable Cooling Unit, Cooling Wrap, Neoprene Strap, and Compression Cap into a continuous-cooling platform that allows patients to remain mobile within the infusion center during treatment.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-01
Description

New York Medicaid added CPT codes for mechanical scalp cooling, expanding access to treatment for cancer patients and improving health equity by reducing barriers to care.

Strategic tierSupportingTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-06-02
Description

Partnered with Glimmer of Hope Foundation to offer portable scalp cooling therapy for breast cancer patients.

Strategic tierSupportingTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-02-04
Description

Launched account at Sharp HealthCare in San Diego as part of expansion to 22 states.

Strategic tierSupportingTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Partnered with St. Clair Health to provide funding support for portable scalp cooling therapy for breast cancer patients.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers5 records
TypeDirect peer
Description

Dignitana is a Swedish company that developed and markets DigniCap, an FDA-cleared scalp cooling system for chemotherapy-induced alopecia. It is the most direct head-to-head competitor to Cooler Heads' Amma, serving the same patient population (solid tumor chemo patients) with the same core mechanism (scalp hypothermia) at cancer centers and infusion facilities.

TypeDirect peer
Description

Paxman is a UK-based manufacturer of FDA-cleared scalp cooling systems used globally to prevent chemotherapy-induced hair loss. It is one of the two established scalp cooling companies competing directly with Cooler Heads' Amma in US oncology centers, with longer market tenure and broader international installed base.

TypeDirect peer
Description

Penguin Cold Caps provides manual, gel-based cold cap systems used by chemotherapy patients to reduce hair loss. While mechanically different from Amma (manual caps requiring dry ice and cap changes vs. automated continuous cooling), Penguin addresses the same patient need and competes for the same oncology hair-preservation use case.

TypeBroad incumbent
Description

Arctic Sun, acquired by Becton Dickinson, is a targeted temperature management system used in hospital critical care settings to control patient body temperature. While not a scalp cooling product, it is a broader medical temperature-management incumbent whose hospital-channel relationships and thermodynamic expertise are adjacent to Cooler Heads' refrigerated therapy device.

TypeEmerging player
Description

Hilotherm is a German manufacturer of medical cooling and compression therapy devices used in oncology, surgery, and sports medicine. Its localized cooling technology overlaps conceptually with Cooler Heads' scalp cooling approach, and it operates as a niche European competitor with partial overlap in hospital cooling indications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cooler Heads

Scalp Cooling Medical Devicescoolerheads.com

Cooler Heads Care develops the Amma portable scalp cooling system, an FDA-cleared medical device that helps chemotherapy patients with solid tumors prevent hair loss. The company sells directly to U.S. infusion centers and cancer treatment facilities from its San Diego headquarters.

What Cooler Heads does

Cooler Heads Care, Inc. is a privately held medical device company headquartered in San Diego, California, founded in 2018 by breast cancer survivor and tech entrepreneur Kate Dilligan. The company develops and commercializes the Amma Scalp Cooling System, an FDA-cleared (K211526) portable mechanical device intended to reduce the likelihood of chemotherapy-induced alopecia in adults 21 and older being treated for solid tumors. The technology circulates chilled fluid through a fitted cooling wrap to lower scalp temperature, constricting blood vessels and limiting chemotherapy delivery to hair follicles; the system comprises a Cooling Wrap, Neoprene Strap, Compression Cap, and Portable Cooling Unit, and is differentiated from traditional cold capping by its continuous cooling (no mid-session cap swaps) and portability within infusion centers.

Cooler Heads sells Amma through a direct enterprise field-sales motion targeting U.S. hospitals, cancer centers, and infusion facilities, providing staff training, demo requests, and onboarding support. As of early 2025 the company reported active accounts in 22 states, with named adopters including Sharp HealthCare, St. Clair Health, OSF Healthcare, UPMC Magee, Detroit Medical Center, Beebe Healthcare, Southeast Georgia Healthcare System, and The Christ Hospital. Healthcare providers bill scalp cooling services using CPT codes 97007, 97008, and 97009; the American Medical Association elevated these codes to Category I effective January 2026, with CMS-proposed payment rates and New York Medicaid coverage effective April 1, 2026 — both meaningful reimbursement tailwinds.

The company has raised approximately $12.5M in disclosed venture funding across a 2021 seed ($1.5M), a 2023 round ($8M), and a July 2025 oversubscribed $11M Series A led by Mutual Capital Partners with participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor. Proceeds are earmarked for manufacturing scale-up, commercial team expansion (including dedicated West and East regional AVP coverage and a market-access function), and next-generation product development. The company employs 11–50 people and operates without a parent company or public listing.

Cooler Heads firmographics

Firmographics
Name
Cooler Heads
Legal name
Cooler Heads Care, Inc.
Website
https://coolerheads.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Cooler Heads Care develops the Amma portable scalp cooling system, an FDA-cleared medical device that helps chemotherapy patients with solid tumors prevent hair loss. The company sells directly to U.S. infusion centers and cancer treatment facilities from its San Diego headquarters.
Ownership category
akta.pro rank

Cooler Heads industry classification

Industry
Product category
Scalp Cooling Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHACAK
Continuous Temperature & Fever Monitoring (Wearable Thermometry)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Scalp cooling system
  • Chemotherapy hair loss prevention
  • Portable medical device
  • Oncology infusion equipment
  • FDA-cleared medical device

Where Cooler Heads is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cooler Heads business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. Device/System Sales to Healthcare Facilities: Cooler Heads provides Amma scalp cooling systems to infusion centers and cancer treatment facilities. Healthcare providers bill using Category I CPT codes (97007, 97008, 97009) for mechanical scalp cooling services. Out-of-pocket expenses vary based on insurance coverage eligibility, plan-specific details, and facility charges.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goInsurance coverage varies by plan

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Cooler Heads product offering

Product offering

Core offering

Cooler Heads sells the Amma Scalp Cooling System, an FDA-cleared portable medical device used in oncology infusion centers to reduce chemotherapy-induced hair loss in adult patients with solid tumors. The system circulates chilled fluid through a fitted wrap before, during, and after chemotherapy treatment to constrict blood vessels and limit chemotherapy delivery to hair follicles. Healthcare facilities acquire the device and bill patients and insurers using Category I CPT codes (97007, 97008, 97009) for mechanical scalp cooling services.

Product overview

Cooler Heads offers the Amma Scalp Cooling System, an FDA-cleared portable medical device designed to help chemotherapy patients prevent hair loss. The system is a unified product consisting of five integrated components: a Portable Cooling Unit that circulates chilled solution, a Cooling Wrap that delivers the solution to the scalp, a Neoprene Strap for compression, and a Compression Cap to hold everything in place. Once fitted, the wrap stays on for the entire session. The system is intended for adults 21 and older with solid tumors and is currently available at participating infusion centers across the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • Amma: FDA-cleared portable scalp cooling system designed to help chemotherapy patients prevent hair loss. Consists of a Cooling Wrap, Neoprene Strap, Compression Cap, and Portable Cooling Unit.

Products and services

  • Amma Scalp Cooling System FDA-cleared portable scalp cooling system designed to help adult (21+) chemotherapy patients with solid tumors prevent hair loss by cooling the scalp before, during, and after treatment. The system is sold to oncology infusion centers and cancer treatment facilities, which then bill patients and insurers using Category I CPT codes (97007, 97008, 97009). The system integrates a Portable Cooling Unit, Cooling Wrap, Neoprene Strap, and Compression Cap into a continuous-cooling platform that allows patients to remain mobile within the infusion center during treatment.

Companies that use Cooler Heads

Customer profile

Named customers9 records

Segments2 records

Ideal customer profiles1 record

Cooler Heads technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cooler Heads partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and supporting.

  • New York MedicaidcoreChannel Partner/ Reseller/ Distributor · 1 April 2026New York Medicaid added CPT codes for mechanical scalp cooling, expanding access to treatment for cancer patients and improving health equity by reducing barriers to care.
  • St. Clair HealthsupportingChannel Partner/ Reseller/ Distributor · 2 June 2025Partnered with Glimmer of Hope Foundation to offer portable scalp cooling therapy for breast cancer patients.
  • Sharp HealthCaresupportingChannel Partner/ Reseller/ Distributor · 4 February 2025Launched account at Sharp HealthCare in San Diego as part of expansion to 22 states.
  • Glimmer of Hope FoundationsupportingGTM or Marketing Partner · 1 January 2025Partnered with St. Clair Health to provide funding support for portable scalp cooling therapy for breast cancer patients.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Cooler Heads competitors and assessment

Company assessment

Direct peers

  • Dignitana: Dignitana is a Swedish company that developed and markets DigniCap, an FDA-cleared scalp cooling system for chemotherapy-induced alopecia. It is the most direct head-to-head competitor to Cooler Heads' Amma, serving the same patient population (solid tumor chemo patients) with the same core mechanism (scalp hypothermia) at cancer centers and infusion facilities.
  • Paxman Scalp Cooling: Paxman is a UK-based manufacturer of FDA-cleared scalp cooling systems used globally to prevent chemotherapy-induced hair loss. It is one of the two established scalp cooling companies competing directly with Cooler Heads' Amma in US oncology centers, with longer market tenure and broader international installed base.
  • Penguin Cold Caps: Penguin Cold Caps provides manual, gel-based cold cap systems used by chemotherapy patients to reduce hair loss. While mechanically different from Amma (manual caps requiring dry ice and cap changes vs. automated continuous cooling), Penguin addresses the same patient need and competes for the same oncology hair-preservation use case.

Broad incumbents

  • Arctic Sun (Becton Dickinson): Arctic Sun, acquired by Becton Dickinson, is a targeted temperature management system used in hospital critical care settings to control patient body temperature. While not a scalp cooling product, it is a broader medical temperature-management incumbent whose hospital-channel relationships and thermodynamic expertise are adjacent to Cooler Heads' refrigerated therapy device.

Emerging players

  • Hilotherm: Hilotherm is a German manufacturer of medical cooling and compression therapy devices used in oncology, surgery, and sports medicine. Its localized cooling technology overlaps conceptually with Cooler Heads' scalp cooling approach, and it operates as a niche European competitor with partial overlap in hospital cooling indications.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cooler Heads social profiles

Digital presence

Cooler Heads compliance and trust

Trust signal

Compliance1 record

Cooler Heads financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cooler Heads leadership team

Management profile

Number of profiles

Profiles15 records

Cooler Heads funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cooler Heads M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cooler Heads

What does Cooler Heads do?

Cooler Heads sells the Amma Scalp Cooling System, an FDA-cleared portable medical device used in oncology infusion centers to reduce chemotherapy-induced hair loss in adult patients with solid tumors. The system circulates chilled fluid through a fitted wrap before, during, and after chemotherapy treatment to constrict blood vessels and limit chemotherapy delivery to hair follicles. Healthcare facilities acquire the device and bill patients and insurers using Category I CPT codes (97007, 97008, 97009) for mechanical scalp cooling services.

Is Cooler Heads a public or private company?

Cooler Heads is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cooler Heads founded?

Cooler Heads was founded in 2018. It employs 11 to 50 people.

Where is Cooler Heads based?

Cooler Heads is headquartered in San Diego, United States, in the North America region.

How does Cooler Heads make money?

One revenue line is on record: device/System Sales to Healthcare Facilities.

Who are Cooler Heads's main competitors?

Direct peers on record are Dignitana, Paxman Scalp Cooling and Penguin Cold Caps. Arctic Sun (Becton Dickinson) is listed as a broad incumbent. Hilotherm is listed as an emerging player.

Does Cooler Heads have an API?

No public API is recorded for Cooler Heads.

What industry is Cooler Heads in?

Cooler Heads's product category is Scalp Cooling Medical Devices. Its primary akta.pro industry code is HLAHACAK, Continuous Temperature & Fever Monitoring (Wearable Thermometry). Its NAICS code is 3391 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCOOLER HEADS AMMA SYSTEM RECOGNIZED BY AETNA AS MEDICALLY NECESSARY FOR HAIR PRESERVATION DURING CHEMOTHERAPYCooler Heads announced that Aetna has recognized scalp cooling, including the Cooler Heads Amma System, as medically necessary for preventing chemotherapy-induced hair loss, as outlined in Aetna's Clinical Policy Bulletin No. 0290 reviewed June 8, 2026. This coverage decision represents a significant milestone expanding access to scalp cooling for millions of cancer patients undergoing chemotherapy. The company stated this policy change alleviates the financial burden on patients and brings scalp cooling closer to becoming the standard of care in cancer treatment.PR NewswireCooler Heads Announces New York Medicaid Coverage for CPT Codes 97007, 97008, and 97009 for Mechanical Scalp CoolingCooler Heads announced that New York Medicaid has added CPT codes 97007, 97008, and 97009 for mechanical scalp cooling to the New York Fee Schedule, effective April 1, 2026. This coverage expansion will provide greater access to scalp cooling services for Medicaid-enrolled cancer patients with solid tumors, helping reduce chemotherapy-induced alopecia. The company's CEO, a cancer survivor herself, emphasized that this milestone advances health equity by making the therapy accessible to patients for whom it would have otherwise been financially out of reach.Pulse 2.0Cooler Heads: $11 Million Series A Raised For Scalp Cooling Technology To Help Chemotherapy PatientsCooler Heads raised $11 million in an oversubscribed Series A led by Mutual Capital Partners to expand manufacturing of its FDA-cleared Amma scalp cooling system. The funds will increase production capacity, expand the commercial team, and develop the next generation of the product.VC News DailyCooler Heads Nabs $11M Series ACooler Heads closed an oversubscribed $11 million Series A funding round led by Mutual Capital Partners. The funds will expand manufacturing capacity, commercial team, and develop the next generation of Amma, its FDA-cleared portable scalp cooling system for chemotherapy patients.InvestorshangoutInnovative Funding to Enhance Scalp Cooling TechnologyCooler Heads raised $11 million in a Series A funding round to accelerate production and distribution of its FDA-cleared Amma scalp cooling system. The funding will support manufacturing expansion, sales growth, and development of the next version of the device. The American Medical Association may classify scalp cooling reimbursement codes as Category I starting January 2026.PR NewswireCooler Heads Secures Series A Funding to Revolutionize Scalp Cooling Technology for Chemotherapy PatientsCooler Heads, a San Diego-based medical device company, has closed an $11M oversubscribed Series A funding round to expand manufacturing and commercial rollout of Amma, the only FDA-cleared portable scalp cooling system designed to help chemotherapy patients prevent hair loss. The round was led by Mutual Capital Partners with participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor, with funds earmarked for increasing manufacturing capacity, expanding the commercial team, and developing next-generation products. The company is positioned to benefit from the American Medical Association elevating scalp cooling reimbursement codes to Category I starting January 2026, which the founder says reinforces scalp cooling as an emerging standard of care.San Diego Union-TribuneSan Diego startup helps cancer patients keep their hair during treatmentSan Diego-based Cooler Heads has secured an $8 million investment to expand distribution of its FDA-cleared Amma scalp-cooling device, which helps chemotherapy patients prevent hair loss. The company recently partnered with healthcare supplier McKesson to distribute the technology to oncology centers and has seen adoption by approximately 20 cancer centers since the device's 2022 launch.PR NewswireCancer Centers Rush to Adopt Cooler Heads' Scalp Cooling System to Meet Strong Patient DemandCooler Heads announced accelerated sales growth for its FDA-cleared Amma scalp cooling device and signed a distribution agreement with McKesson to expand access for oncology customers. The company's expansion is driven by strong patient demand, Medicare reimbursement approval, and adoption by over 20 cancer centers seeking affordable side-effect management solutions.HomepageMedtech Company Cooler Heads Adds $1.5M in New Funding After Receiving FDA Clearance to Help Save Cancer Patients’ HairMedtech company Cooler Heads announced FDA clearance for its scalp cooling device designed to help cancer patients undergoing chemotherapy preserve their hair, followed by a $1.5 million funding round. This latest investment brings the company's total raised capital to $3.1 million from investors including Robin Hood Ventures and Anathem Ventures. Cooler Heads plans to begin serving patients in Q1 2022 following the closure of this oversubscribed funding round.PR NewswireCooler Heads Receives FDA Clearance To Help Save Cancer Patients' HairCooler Heads received FDA clearance to sell its Amma scalp cooling device, enabling cancer patients undergoing chemotherapy to preserve their hair. The company achieved this regulatory milestone with less than $1.5 million in venture capital funding and has secured additional investment to support commercialization. Cooler Heads plans to begin serving patients in the first quarter of 2022 following the signing of multiple commercial partnerships.